AGP Executive Report

Aging & Nutrition: Japan’s National Center for Geriatrics and Gerontology reports that people who ate more mushrooms scored higher on memory tests in a decade-long observational study of 3,162 adults, with benefits strongest at moderate-to-high intake (correlation, not proof of cause). Wellness Tradition: A separate wellness explainer spotlights natto and nattokinase, noting how fermented foods may fit daily routines but warning people on blood thinners or facing surgery to check with clinicians first. Pediatric Care Innovation: A virtual zoo program is helping children in Japanese hospitals with long stays—VR trips to places like Osaka’s Tennoji Zoo aim to reduce isolation and boost morale during treatment. Mental Health Science: University of Fukui researchers report mouse findings linking dopamine-related brain changes to ADHD-like behaviors, pointing to possible future targets for harder-to-treat cases. Public Health Milestone: Japan’s centenarian population has topped 100,000 for the first time, reaching 107,677, according to Health Ministry figures. Medical Devices & Sleep: Coverage also highlights a new narcolepsy drug approved in the US and a cuffless ring blood pressure monitor targeting next-year FDA steps, underscoring ongoing device and treatment momentum.

Aging Milestone: Japan’s Health Ministry says the number of people aged 100+ has topped 100,000 for the first time, reaching 107,677 (about 88% women), highlighting both longevity gains and the pressure on a sustainable social security system. Diet & Brain Health: A decade-long Japanese cohort study links higher mushroom intake with better short-term and working memory scores, while stressing the results show correlation, not cause. Infectious Disease Research: Japanese researchers report that direct-acting hepatitis C drugs cleared long-standing hepatitis C infection in chimpanzees, including animals infected decades ago—an animal-welfare and translational science win. Public Health Alert: Nepal’s Japanese encephalitis outbreak has reached 26 deaths, with all fatalities among unvaccinated patients and most victims aged over 50. Healthcare Access & Training: Japanese cardiac specialists are set to run a 10-day free surgery camp at Kenya’s Kenyatta National Hospital, aiming to treat patients and train local teams. Healthcare Cybersecurity: US provider Premier Medical Group says a June breach exposed data for 282,075 people, urging patients to check statements for unfamiliar services. Gender Equality Watch: The World Economic Forum’s Global Gender Gap Report ranks Japan 117th out of 145 economies, improving slightly but still worst among G7, with health and survival ranking relatively stronger than politics and economics.

Aging Milestone: Japan’s centenarians have topped 100,000 for the first time, reaching 107,677 people aged 100+ (about 88% women), underscoring how medical advances are keeping older adults active. Care Innovation: A virtual zoo program is letting children in Japanese hospitals explore places like Osaka’s Tennoji Zoo via VR, aiming to ease isolation during long cancer and serious illness stays. Nutrition & Brain Health: A decade-long Japanese study links higher mushroom intake with better short-term and working memory scores in middle-aged and older adults, while stressing it shows correlation, not cause. End-of-Life System Pressure: Japan’s “unclaimed bodies” trade is expanding, with some private firms storing remains in warehouses and charging municipalities low fees—raising concerns about oversight and transparency. Rare Disease Treatment: Japan has approved a new treatment option for a rare genetic liver disorder, adding to the growing pipeline of targeted therapies. Menopause Drug Explained: Coverage breaks down how the menopause drug Veoza works differently from hormone therapy for hot flushes and night sweats. Pediatrics & Family Support: Ronald McDonald House Kyoto broke ground to give families a home-like base near major hospitals while children receive treatment. Health Tech Funding: RegCell secured $66 million in Japan-linked funding to move immune-tolerance cell therapy toward the clinic for autoimmune diseases. Digital Health Research: Singapore’s precision medicine push is highlighted as a way to speed clinical-trial matching and improve diagnoses.

Longevity Milestone: Japan’s Ministry of Health says the number of people aged 100+ has topped 100,000 for the first time, reaching 107,677 (mostly women), underscoring both medical success and rising welfare costs. Sleep & Wellness Trends: A Tokyo “90-minute napping tournament” will pay a Sh1.8 million prize, using medical-grade sleep trackers and doctor scoring—plus a separate study links higher air pollution to more nighttime coughing, even below WHO daily limits. Brain & Exercise: Research highlighted by a Japanese exercise expert suggests just 10 minutes of super-slow running can quickly improve brain activity, thinking, and mood. Diet for Cognition: A decade-long Japanese study reports higher mushroom intake is associated with better memory test performance in middle-aged and older adults (correlation, not proof of cause). Cancer & Diagnostics: Allarity won a Japanese patent for its stenoparib DRP companion diagnostic, while BlossomHill shared updated early trial data for BH-30643 in EGFR C797S-positive lung cancer. Women’s Health Tech: Intuitive received CE mark approval to expand use of its da Vinci SP system for transvaginal gynecological procedures. Public Health Watch: A report notes growing non-medical use of Mounjaro for weight loss in Japan, with consumer inquiries and concerns about rapid weight loss. Human Story: Actress Yuri Nakamura, 44, died after a rectal cancer recurrence and metastasis, according to her agency.

Cognitive Health & Diet: Japan’s National Center for Geriatrics and Gerontology reports a decade-long observational study linking higher mushroom intake with better short-term and working memory scores in middle-aged and older adults, while stressing it shows correlation, not cause. Wellness Tradition Meets Evidence: A separate wellness explainer highlights natto and nattokinase as a centuries-old Japanese fermented food, noting potential benefits and key safety cautions for people on blood thinners or preparing for surgery. Drug Pricing Policy Watch: A Lancet modeling study warns the US Medicare “Most-Favoured-Nation” pricing approach could push manufacturers to raise prices outside the US or delay launches, reshaping global pharma access. Japan Clinical/Regulatory Signals: Takeda says Phase 3 NEJM data for oveporexton (Orzeyful) in narcolepsy type 1 show improvements across wakefulness and quality of life, reinforcing its disease-targeting potential. Medical Tech Collaboration: Aptar and Massachusetts General Hospital announce a nose-to-brain drug delivery research collaboration aimed at more reliable intranasal pathways. Public Health & Safety: After Chiba’s August downpours, some condo residents still face elevator outages and water issues a month later, underscoring lingering health and mobility impacts. Workplace/Industrial Health Incident: Jordan’s Aqaba reports 11 injured after an ammonia gas leak during maintenance at a Japanese company site, with authorities reviewing safety procedures.

Cognitive Health & Diet: Japan’s National Center for Geriatrics and Gerontology reports a decade-long observational study linking higher mushroom intake with better memory scores in middle-aged and older adults, while stressing the results show correlation, not cause. Wellness Supplements: A separate wellness explainer spotlights natto and nattokinase, including how enzyme activity is measured and key cautions for people on blood thinners or facing surgery. Blood Collection Innovation: Bora Biologics says it scaled up and is supplying RAPClot protein for Q Sera’s RAPClot technology, supporting Terumo’s Japan launch of RAPClot blood collection tubes. Drug Development Update: Takeda’s zasocitinib gets an FDA priority review acceptance for moderate-to-severe plaque psoriasis, while MediWound’s EscharEx Phase III VALUE study is cleared to continue without modification after a DSMB review. Public Health & Access: Japan’s Supreme Court rejects a Ghanaian man’s appeal over public assistance eligibility for non-citizens, reinforcing the current welfare law limits. Medical Supply Diplomacy: South Korea says it is ready to provide UN-approved medical equipment to North Korea if requested, citing a planned supply list for a Pyongyang hospital. Healthcare Tech/AI & Markets: Asian markets slide as AI-linked stocks drop amid calls to slow frontier AI development, adding pressure to the broader investment mood.

Cognitive Health & Diet: Japan’s National Center for Geriatrics and Gerontology reports a decade-long observational study linking higher mushroom intake with better short-term and working memory scores in middle-aged and older adults, while stressing the results show correlation, not cause. Wellness Supplements: A separate wellness explainer spotlights natto and nattokinase, noting how enzyme activity is typically measured and flagging cautions for people on blood thinners or preparing for surgery. Cancer Treatment Update: Taiho Oncology and partners report Phase 3 REZILIENT3 results: zipalertinib plus chemotherapy improved median progression-free survival by 6.0 months for first-line EGFR exon 20 insertion NSCLC, with overall survival follow-up ongoing. Public Health Incident (Japan): At Kyoto’s Takebishi Stadium, 28 people were hospitalized after suspected food poisoning at a corporate athletics event, with two cases reported as serious. Mobility & Longevity: A study in the British Journal of Sports Medicine suggests health benefits from walking don’t require 10,000 steps; walking pace matters, and a sustained moderate pace may help across step counts. Disaster Response (Regional): Indonesia’s Java Sea ferry disaster continues with 108 rescued and at least 129 missing after a capsizing in rough weather. Healthcare Tech/Training (Asia): A Seoul clinic director demonstrated periorbital radiofrequency treatment at a Lutronic Academy session, drawing about 1,400 clinicians.

Cognitive Health & Diet: Japan’s National Center for Geriatrics and Gerontology reports a decade-long study linking higher mushroom intake with better short-term and working memory scores in middle-aged and older adults, while stressing it shows correlation, not cause. Sleep Medicine: The FDA approved a new narcolepsy drug, Orzeyful, aiming to replace missing orexin-related biology for people with type 1 narcolepsy—an advance for patients who still struggle with daily functioning. Prevention & Fitness: A large study in the British Journal of Sports Medicine suggests that walking faster can lower early-death risk even for people who log fewer than 5,000 steps a day, shifting the focus from step counts alone to pace. Shingles Risk in Aging: A review highlights how herpes zoster risk rises with age and immunosuppression, and why prevention matters for avoiding painful complications like postherpetic neuralgia. Japan Health Policy & Preparedness: Japan is sending equipment to help Indonesia fight wildfire-linked haze, as regional partners expand disaster and medical readiness efforts. Local Governance: Okinawa voters head to the polls in a gubernatorial race where U.S. base relocation and economic policy are key issues.

Nutrition & Brain Health: Japan’s National Center for Geriatrics and Gerontology reports that higher mushroom intake in a decade-long cohort of 3,162 adults was linked with better short-term and working memory scores, though researchers stress it’s correlation, not proof of cause. Traditional Wellness: A separate wellness explainer highlights natto’s fermented soybean benefits, including nattokinase, while warning people on blood thinners or facing surgery to consult clinicians first. Food Safety in Japan: Kyoto officials report 28 people hospitalized after suspected food poisoning from boxed lunches at a stadium event, with vomiting and diarrhea among symptoms. Health Tech & Prevention: A case-focused piece on university exam cheating describes how wearable cameras and hidden earpieces are being used by contract cheating networks, raising new risks for student integrity and campus safeguards. Medical Research Recognition: Multiple reports note Japanese researchers winning major U.S. Lasker Awards for medicine, underscoring continued momentum in clinical science.

Cognitive Health & Diet: Japan’s National Center for Geriatrics and Gerontology reports that higher mushroom intake in a decade-long cohort of 3,162 adults was linked with better short-term and working memory scores, even after adjusting for diet quality, health conditions and socioeconomic factors—though researchers stress it’s correlation, not proof of cause. Traditional Nutrition Spotlight: A wellness explainer highlights natto’s long history and its enzyme nattokinase, noting how supplement dosing can be easier than eating natto, while flagging cautions for people on blood thinners or facing surgery. Stroke Care Innovation: A new review in the Journal of Neurology maps how stent retrievers have reshaped acute ischemic stroke treatment and what’s next for clot-removal technology. Clinical Screening in Dementia: Another study focuses on explainable machine learning for dysphagia screening in people with dementia, aiming to catch swallowing risks earlier. Japan Health Policy & Services: Coverage notes Japan’s Department of War extends a health insurance pilot for civilian employees and dependents, underscoring ongoing efforts to broaden access.

Cognitive Health: Japan’s National Center for Geriatrics and Gerontology reports that higher mushroom intake in a decade-long cohort of 3,162 adults was linked with better short-term and working memory scores, even after adjusting for diet quality and health factors—though researchers stress it’s correlation, not proof of cause. Wellness Nutrition: A separate wellness explainer highlights natto and nattokinase, noting how enzyme activity is measured and flagging cautions for people on blood thinners or before surgery. Sleep Science: UT Southwestern sleep researcher Masashi Yanagisawa received the 2026 Lasker Award for discovering orexin’s role in wakefulness, a breakthrough tied to new treatments for narcolepsy and insomnia. Clinical Oddities (Japan): Case reports describe rare conditions triggered by infection or allergens: a 4-year-old with face distortion after a respiratory illness, and a woman whose nighttime anaphylaxis was traced to proteins in her partner’s semen. Fitness Guidance: A large study challenges the “10,000 steps” rule, suggesting walking pace may matter more for lowering early death risk. Regional Health Policy: ASEAN and Japan announced a more structured health partnership focused on healthy ageing and universal health coverage.

Cancer Care Update: AstraZeneca reported phase 3 results showing Imfinzi (durvalumab) plus Imdelltra (tarlatamab) improved overall survival versus Imfinzi alone as first-line maintenance for extensive-stage small cell lung cancer, with gains also in progression-free survival and response rate. Regulatory Watch: Spectral Medical said the FDA’s 100-day PMA review for Toraymyxin (PMX) included a deficiency letter, but the company does not expect a material change to its regulatory timeline after the in-person meeting. Food & Public Health: Multnomah County health inspections flagged serious food-safety and sanitation problems at multiple restaurants, including temperature control failures, mold, and rodent activity. Wellness & Nutrition: A new report highlights natto and nattokinase as a centuries-old Japanese wellness staple, while stressing that supplement potency should be measured by activity and that people on blood thinners or facing surgery should consult clinicians first. Japan Health Policy/Systems: South Korea’s newly launched guardianship trust association plans to benchmark Japan’s legal support model as demand rises in a super-aged society. Clinical Research: A study on orexin’s discovery—recognized by the Lasker Basic Medical Research Award—underscores how sleep-wake biology is driving new treatments for insomnia and narcolepsy.

Sports Medicine & Athlete Care: Aspetar’s multidisciplinary team is running a dedicated medical clinic for Qatar’s delegation at the Aichi-Nagoya 2026 Asian Games, covering pre- and in-competition care for 427 athletes across 26 sports. Nutrition & Supplements: Japan’s protein powder market is getting hit by rising whey costs tied to overseas demand and the weak yen, pushing consumers to cut back or change how they buy. Clinical Research Oversight: The FDA says it will tighten scrutiny of global clinical trial data, including more foreign inspections and clearer transparency on findings—an issue for sponsors relying on ex-US studies. Public Health & Safety: Japan is deploying equipment to help fight Indonesia’s Borneo wildfires and toxic haze, as satellite monitoring highlights large emissions from peat fires. Workplace Wellbeing: Singapore leads Southeast Asia on Great Place to Work’s 2026 Asia list with 25 firms, including major representation from IT and healthcare-linked sectors. Health Tech & Privacy: Apple Watch Series 12/Ultra 4 add Sound Recognition and Live Rewind, but some health-related features depend on newer hardware and iPhone support. Food & Wellness Trend: Natto and nattokinase are being promoted again as a centuries-old wellness staple, with emphasis on enzyme activity and safety for people on blood thinners.

Vaccine Access: GSK won Japanese approval for a new ready-to-use prefilled syringe format of its Shingrix shingles vaccine, aiming to simplify administration by removing the manual mixing step; Japan sees about 1.1 million shingles cases annually, with higher risk in older adults and people with weakened immunity. Healthcare Innovation: Japan’s Kyoto Kagaku showcased long-running healthcare simulation training collaboration with India’s Father Muller Simulation & Skill Centre, highlighting how simulation equipment and skill trainers are being used for hands-on education and staff development. Public Health & Environment: Japan deployed a military transport ship and helicopters to help Indonesia fight Borneo wildfires, as toxic haze has triggered major respiratory illness spikes in the region. Care Delivery Systems: A regional hospital connectivity push is raising the stakes on interoperability, with leaders warning that AI and digital tools only deliver real gains when they plug into clinical workflows and share data across systems. Research Recognition: Japanese scientists and collaborators received major international honors for work tied to narcolepsy’s underlying cause, reinforcing momentum in sleep medicine and translational research.

Cardiology & AI Diagnostics: A China-Japan team reports a vectorcardiography-enhanced model that turns standard ECG signals into a 3D electrical map, estimating one-year major cardiac event risk in chronic heart failure with high discrimination—if validated externally, it could sharpen how clinicians triage patients after discharge. Ophthalmology & Kids’ UV Safety: Japanese experts warn that protecting children’s eyes from UV needs more than sunscreen; clear lenses can let UV penetrate deeper, and they recommend hats/parasols/sunglasses plus UV-blocking lens coatings, with attention to when and how kids are exposed. Medical Research Recognition: Four Japanese researchers win the U.S. Lasker Awards in medicine, including sleep science work identifying orexin and hemophilia breakthroughs tied to Chugai’s Hemlibra—another reminder of Japan’s research momentum. Infectious Disease Pipeline: Shionogi says it will share new anti-infective data at IDWeek 2026, spanning COVID antivirals and Gram-negative antibiotics, as it highlights ongoing clinical milestones. Healthcare Data Infrastructure: Mitsui plans to combine anonymized patient data across Asia hospital networks to help pharma find trial participants faster, aiming to speed drug development. Workplace Health & Safety: Myanmar workers in Hokkaido allege violence and intimidation at a farm employing foreign workers under Japan’s specified skilled worker program, raising fresh concerns about protections for migrant care and labor.

Cancer Research & Drug Development: Adagene said it hit a preclinical milestone in its Exelixis collaboration, triggering a $2.0m payment tied to its SAFEbody® antibody-drug conjugate candidate XB404, plus additional payments linked to candidate selection. Clinical Breakthroughs in Liver Disease: Can-Fite published a peer-reviewed case report in Japan describing Namodenoson treatment in decompensated cirrhosis, with ascites resolution and regression of esophageal varices, enabling a successful liver transplant after ~28 months. Public Health—Vaccines: Nepal launched a Japanese encephalitis vaccination campaign in Jhapa and Kailali starting in early October, targeting adults 30+ in the first phase due to rising cases and deaths. Healthcare Access & Support: In Toronto, a new Women’s Health Van (Haleon Canada, GlobalMedic, Shoppers Foundation for Women’s Health) will bring products, education, and care navigation to underserved communities across the GTA. Medical Devices & Evidence: A Cochrane review found lumbar supports offer little to no improvement for chronic low back pain, with only a possible short-term pain reduction when combined with medication. Healthcare Tech: Researchers reported an AI-assisted, label-free SERS microfluidic chip that can identify and sort cancer cells with 96.2% accuracy. Global Health & Resilience: After Nepal’s Bhote Koshi–Trishuli floods, a new proposal focuses on “smart settlements” to strengthen relocation, reconstruction, and climate-friendly planning.